Canary Speech Named to the 2024 CB Insights’ List of the 50 Most Innovative Digital Health Startups
Canary Speech (Provo, Utah) has been recognized by CB Insights for its achievements in non-invasive diagnostics.
Tech News
Provo, Utah, December 3, 2024
Today Canary Speech was listed by CB Insights in its 2024 Digital Health 50 — a list of the world's 50 most promising private digital health companies, selected based on a combination of data signals and proprietary scoring.
Canary Speech, based in Provo, Utah, has developed vocal biomarker technology offering a wide range of applications within the healthcare industry, including ambient clinical listening, remote patient monitoring, and annual wellness checks. Ambient listening tools, which are systems designed to unobtrusively capture and analyze conversations in real-time, enable healthcare providers to focus on patient interactions while automatically documenting clinical notes.
From a pool of 10,000+ digital health startups, CB Insights analyzed companies using its proprietary metrics — Commercial Maturity and Mosaic scores — along with additional data on partnerships, funding, patents, leadership, and headcount. CB Insights supplemented this analysis with direct company submissions via Analyst Briefings.
“The 2024 Digital Health 50 cohort highlights high-momentum companies driving meaningful change across healthcare,” said Amrit Panjabi, Intelligence Analyst at CB Insights. “This year’s winners are at the forefront of bringing an AI-driven infrastructure to healthcare, transforming diagnostics, and bringing condition-specific care platforms to patients and providers. These companies are accelerating the transformation of healthcare delivery, streamlining workflows, and advancing patient outcomes globally.”
“We are thrilled to be recognized by CB Insights as one of the 50 most innovative digital health startups,” said Henry O’Connell, CEO of Canary Speech. “We’re proud to be selected by such a respected entity for our non-invasive diagnostics solution.”
Canary Speech is an AI-powered voice biomarker health tech company that uses real-time patented vocal analysis to screen for mental health and neurological disorders. Canary’s vocal biomarker technology has a wide range of applications within the healthcare industry including contact centers, ambient clinical listening, remote patient monitoring, and annual wellness checks. Ambient listening tools, which are systems designed to unobtrusively capture and analyze conversations in real-time, enable healthcare providers to focus on patient interactions while automatically documenting clinical notes. Canary Speech’s patent portfolio now has 14 patents (8 issued and 6 pending), leading all competitors in the industry for awarded patents. Based on its unique approach, Canary Speech uses vocal biomarkers that capture a data set of over 15 million data elements every minute of conversational speech to establish their extensive set of patents.
CB Insights provides market intelligence using AI built on a validated database of companies and markets.. It delivers instant insights on markets, competition and other topics for its clients.
CB Insight's Digital Health 50 for 2024 features the following highlights:
- $3.5B in equity funding raised over time, including more than $1.5B in 2024 so far (as of 11/14/2024)
- 72% of winners are building AI products, addressing everything from drug development to treatment selection to clinical documentation
- 56% of winners are early-stage companies (seed or Series A)
- Winners from 9 countries across the globe: the United States, Germany, Canada, Israel, South Korea, the United Kingdom, New Zealand, Belgium, and France
- 200+ business relationships since 2022, including with industry leaders like Nvidia and Kaiser Permanente